{"entity":{"id":"cencec-cuba","kind":"institution","name":"National Coordinating Centre of Clinical Trials, Cuba (CENCEC)","aka":["CENCEC","Centro Nacional Coordinador de Ensayos Clínicos","RPCEC","Registro Público Cubano de Ensayos Clínicos","Cuban Public Registry of Clinical Trials"],"tldr":"The Ministry of Public Health centre that coordinates clinical trials in Cuba and runs the Cuban Public Registry of Clinical Trials, set up in 2007 and listed by WHO as a primary registry.","summary":"The Cuban Public Registry of Clinical Trials (RPCEC) was established in 2007 under the leadership of the National Coordinating Centre of Clinical Trials (CENCEC) and has national coverage. Its home page states that a trial must obtain an RPCEC code before the first patient is recruited, as established by Resolution 435 of 2017 of the Ministry of Public Health, the clinical trials regulation, and that for trials authorised by CECMED the code must be sent to CECMED before it issues the authorisation certificate. Registered trials are not removed from public view, and sponsors submit their data in both Spanish and English. The registry shares a building with CECMED at Calle 5ta A, Miramar, Playa, Havana; the coordinates are approximate.\n\nWHO lists the RPCEC among the primary registries of its International Clinical Trials Registry Platform. Earlier trials, such as the randomised trial of nimotuzumab with radiotherapy in high-grade glioma published in 2013, cite the Cuban National Register for clinical trials.","asOf":"2026-11-11","links":[{"label":"RPCEC: welcome to the Cuban Registry of Clinical Trials (read through the Internet Archive)","url":"https://web.archive.org/web/2026/https://rpcec.sld.cu/en/home"},{"label":"WHO: primary registries in the WHO registry network","url":"https://www.who.int/tools/clinical-trials-registry-platform/network/primary-registries"},{"label":"CECMED: clinical evaluation (Spanish; read through the Internet Archive)","url":"https://web.archive.org/web/2026/https://www.cecmed.cu/evaluacion-clinica"}],"tags":[],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["cuba-minsap","cecmed"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":["paper-solomon-nimotuzumab-high-grade-glioma-bmc-cancer-2013","paper-rodriguez-cimavax-egf-phase3-nsclc-ccr-2016","paper-alfonso-racotumomab-maintenance-nsclc-ccr-2014"],"journals":[],"dependsOn":[],"notes":[],"city":"Havana","country":"CU","lat":23.115,"lng":-82.441,"institutionType":"government","website":"https://rpcec.sld.cu","programs":["Registro Público Cubano de Ensayos Clínicos (from 2007)","Coordination of clinical trials for the national health system"]},"route":"/institutions/cencec-cuba/","neighbours":{"institution":[{"id":"cecmed","kind":"institution","name":"Center for State Control of Medicines, Equipment and Medical Devices (CECMED)","route":"/institutions/cecmed/"},{"id":"cuba-minsap","kind":"institution","name":"Ministry of Public Health, Cuba (MINSAP)","route":"/institutions/cuba-minsap/"}],"paper":[{"id":"paper-rodriguez-cimavax-egf-phase3-nsclc-ccr-2016","kind":"paper","name":"CIMAvax-EGF as switch maintenance in advanced non-small cell lung cancer: the Cuban phase III trial","route":"/key-papers/paper-rodriguez-cimavax-egf-phase3-nsclc-ccr-2016/"},{"id":"paper-solomon-nimotuzumab-high-grade-glioma-bmc-cancer-2013","kind":"paper","name":"Nimotuzumab or placebo with radiotherapy for high-grade glioma: a Cuban randomised double-blind trial","route":"/key-papers/paper-solomon-nimotuzumab-high-grade-glioma-bmc-cancer-2013/"},{"id":"paper-alfonso-racotumomab-maintenance-nsclc-ccr-2014","kind":"paper","name":"Racotumomab-alum vaccine as switch maintenance in advanced non-small cell lung cancer: a randomised placebo-controlled trial","route":"/key-papers/paper-alfonso-racotumomab-maintenance-nsclc-ccr-2014/"}]}}